HomeACRS • NASDAQ
add
Aclaris Therapeutics Inc
Previous close
$3.13
Day range
$2.85 - $3.14
Year range
$1.05 - $4.89
Market cap
310.95M USD
Avg Volume
2.49M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 1.30M | -85.94% |
Operating expense | 5.58M | 12.56% |
Net income | -19.80M | 79.50% |
Net profit margin | -1.53K | -45.83% |
Earnings per share | -0.16 | 84.16% |
EBITDA | -22.32M | -59.15% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | — | — |
Total assets | — | — |
Total liabilities | — | — |
Total equity | — | — |
Shares outstanding | — | — |
Price to book | — | — |
Return on assets | — | — |
Return on capital | -45.64% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -19.80M | 79.50% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2012
Website
Employees
69
